Armistice Capital »

First Financial Ban shares owned by Armistice Capital

Quarter-by-quarter ownership of First Financial Ban (FFBC) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in First Financial Ban

Tip: Access up to 7 years of quarterly data

All positions including First Financial Ban held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Financial Ban by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $251k 9.0k 27.88

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding First Financial Ban

BlackRock
Vanguard Group
Dimensional Fund Advisors
Vanguard Portfolio Management
State Street Corporation
Nomura Asset Management International
Vanguard Capital Management
Fort Washington Investment Advisors
Geode Capital Management
First Trust Advisors
Hanna Zanoni
Victory Capital Management
Charles Schwab Investment Management
Bahl & Gaynor
Northern Trust

View all funds holding First Financial Ban